Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Roth

Showing results (851-860 of 940) with videos related to

Pageof 94
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3Eric Van Cutsem, Roberto Labianca, György Bodoky, et al.
Plos One|August 4, 2012
A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterationsTao Xie, Giovanni D' Ario, John R Lamb, et al.
Neurourology and Urodynamics|June 8, 2020
Contemporary multicenter outcomes of continent cutaneous ileocecocystoplasty in the adult population over a 10-year period: A Neurogenic Bladder Research Group studyPhilip J Cheng, Sorena Keihani, Joshua D Roth, et al.
Journal of Medicinal Chemistry|March 26, 1998
alpha-Substituted malonester amides: tools to define the relationship between ACAT inhibition and adrenal toxicityD R Sliskovic, J A Picard, P M O'Brien, et al.
Cancer|January 10, 2018
Long-term outcome of dasatinib first-line treatment in gastrointestinal stromal tumor: A multicenter, 2-stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07)Michael Montemurro, Angela Cioffi, Julien Dômont, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trialDaniel C Betticher, Shu-Fang Hsu Schmitz, Martin Tötsch, et al.
British Journal of Cancer|April 20, 2006
Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II studyD C Betticher, S-F Hsu Schmitz, M Tötsch, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2007
Hepatoselectivity of statins: design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitorsWilliam K C Park, Robert M Kennedy, Scott D Larsen, et al.
Journal of Medicinal Chemistry|June 7, 1996
Inhibitors of acyl-CoA:cholesterol O-acyltransferase. synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide and structurally related tetrazole amide derivativesP M O'Brien, D R Sliskovic, J A Picard, et al.
Hepatology Communications|November 25, 2024
Aberrant basement membrane production by HSCs in MASLD is attenuated by the bile acid analog INT-767Prakash Ramachandran, Madara Brice, Elena F Sutherland, et al.
Pageof 94

Showing results (851-860 of 940) with videos related to

Sort By:
Pageof 94
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2009
Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3Eric Van Cutsem, Roberto Labianca, György Bodoky, et al.
Plos One|August 4, 2012
A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterationsTao Xie, Giovanni D' Ario, John R Lamb, et al.
Neurourology and Urodynamics|June 8, 2020
Contemporary multicenter outcomes of continent cutaneous ileocecocystoplasty in the adult population over a 10-year period: A Neurogenic Bladder Research Group studyPhilip J Cheng, Sorena Keihani, Joshua D Roth, et al.
Journal of Medicinal Chemistry|March 26, 1998
alpha-Substituted malonester amides: tools to define the relationship between ACAT inhibition and adrenal toxicityD R Sliskovic, J A Picard, P M O'Brien, et al.
Cancer|January 10, 2018
Long-term outcome of dasatinib first-line treatment in gastrointestinal stromal tumor: A multicenter, 2-stage phase 2 trial (Swiss Group for Clinical Cancer Research 56/07)Michael Montemurro, Angela Cioffi, Julien Dômont, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trialDaniel C Betticher, Shu-Fang Hsu Schmitz, Martin Tötsch, et al.
British Journal of Cancer|April 20, 2006
Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II studyD C Betticher, S-F Hsu Schmitz, M Tötsch, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2007
Hepatoselectivity of statins: design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitorsWilliam K C Park, Robert M Kennedy, Scott D Larsen, et al.
Journal of Medicinal Chemistry|June 7, 1996
Inhibitors of acyl-CoA:cholesterol O-acyltransferase. synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide and structurally related tetrazole amide derivativesP M O'Brien, D R Sliskovic, J A Picard, et al.
Hepatology Communications|November 25, 2024
Aberrant basement membrane production by HSCs in MASLD is attenuated by the bile acid analog INT-767Prakash Ramachandran, Madara Brice, Elena F Sutherland, et al.
Pageof 94